HomeProductsBioactive CompoundsJAK/STAT SignalingJAKSolcitinib
Chemical structure of CAS 1206163-45-2

Solcitinib

In Stock•Starting at $26 for 1 mg•Purity ≥ 98%
CAS No.1206163-45-2
MDL No.MFCD26960569
MFC22H23N5O2
MW389.40
InChI KeyMPYACSQFXVMWNO-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98%$26In Stock
5 mg98%$31In Stock
10 mg98%$50In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1206163-45-2
Product NameSolcitinib

Biological Targets

JAK1

Associated Conditions

systemic lupus erythematosus·psoriasis·ulcerative colitis
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

Safety, tolerability, efficacy and pharmacodynamics of the selective JAK1 inhibitor GSK2586184 in patients with systemic lupus erythematosus.

Lupus • Vol. 25, Issue 13 • 2016
PMID: 27055521DOI: 10.1177/0961203316640910

Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study.

The British journal of dermatology • Vol. 174, Issue 5 • 2016
PMID: 26785220DOI: 10.1111/bjd.14399

Induction of corneal graft rejection by passive cell transfer.

Investigative ophthalmology • Vol. 15, Issue 2 • 1976
PMID: 1357

Documentation

Similar Products